Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-10416.44%
operating margin TTM
1448.63%
revenue TTM
3.14 Thousand
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -14.43 |
| peg ratio | -0.66 |
| price to book ratio | -56.90 |
| price to sales ratio | 16.33 |
| enterprise value multiple | -0.19 |
| price fair value | -56.90 |
profitability ratios | |
|---|---|
| gross profit margin | 77.4% |
| operating profit margin | 1448.63% |
| pretax profit margin | -10416.44% |
| net profit margin | -10416.44% |
| return on assets | -243.41% |
| return on equity | -1586.23% |
| return on capital employed | -60.1% |
liquidity ratio | |
|---|---|
| current ratio | 0.26 |
| quick ratio | 0.26 |
| cash ratio | 0.09 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 47.50 |
| days of payables outstanding | 76,804.85 |
| cash conversion cycle | -76,757.35 |
| receivables turnover | 7.68 |
| payables turnover | 0.00 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.09 |
| debt equity ratio | -0.15 |
| long term debt to capitalization | -0.10 |
| total debt to capitalization | -0.17 |
| interest coverage | 3.32 |
| cash flow to debt ratio | -26.03 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.22 |
| cash per share | 0.01 |
| operating cash flow per share | -0.21 |
| free cash flow operating cash flow ratio | 1.04 |
| cash flow coverage ratios | -26.03 |
| short term coverage ratios | -63.62 |
| capital expenditure coverage ratio | -26.78 |
Frequently Asked Questions
When was the last time AIM ImmunoTech Inc. (AMEX:AIM) reported earnings?
AIM ImmunoTech Inc. (AIM) published its most recent earnings results on 15-05-2025.
What is AIM ImmunoTech Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. AIM ImmunoTech Inc. (AMEX:AIM)'s trailing twelve months ROE is -1586.23%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. AIM ImmunoTech Inc. (AIM) currently has a ROA of -243.41%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did AIM's net profit margin stand at?
AIM reported a profit margin of -10416.44% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is AIM's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.26 in the most recent quarter. The quick ratio stood at 0.26, with a Debt/Eq ratio of -0.15.